Both a medical doctor, an OBOT provider, and an OTP director, Yngvild Olsen, M.D. is well-known to the methadone and buprenorphine treatment fields. Last month she became the acting director of the Center for Substance Abuse Treatment (CSAT) at the federal Substance Abuse and Mental Health Services Administration. The announcement appeared on the SAMHSA website January 21, 2022.
